IN VITRO PHARMACODYNAMIC EFFECTS OF CANGRELOR ON PLATELET P2Y12 RECEPTOR MEDIATED SIGNALING IN TICAGRELOR TREATED PATIENTS

IN VITRO PHARMACODYNAMIC EFFECTS OF CANGRELOR ON PLATELET P2Y12 RECEPTOR MEDIATED SIGNALING IN TICAGRELOR TREATED PATIENTS

Methods This was a prospective study conducted in patients (n=60) on ticagrelor 90mg bid maintenance therapy after an acute coronary syndrome who were randomized to receive either a 90mg or 180mg reload of ticagrelor.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.213-213
Hauptverfasser: Rollini, Fabiana, Franchi, Francesco, Thano, Estela, Faz, Gabriel, Park, Yongwhi, Hu, Jenny, Kureti, Megha, Aggarwal, Niti, Durairaj, Ashwin, Cho, Jung Rae, Been, Latonya, Alobaidi, Zeina, Zenni, Martin, Bass, Theodore, Angiolillo, Dominick
Format: Artikel
Sprache:eng
Schlagworte:
Acute coronary syndromes
Cardiology
Cardiovascular
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods This was a prospective study conducted in patients (n=60) on ticagrelor 90mg bid maintenance therapy after an acute coronary syndrome who were randomized to receive either a 90mg or 180mg reload of ticagrelor.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(16)30214-5